2026 Mario P. Colombo: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	105	590	544	16	14	669	42376
Medicine	107	6228	5859	196	183	700	44028

Overview

Mario P. Colombo is affiliated with the Fondazione IRCCS Istituto Nazionale dei Tumori in Italy. Their scientific work primarily intersects medicine, immunology, and molecular biology, focusing on cancer research and immune system interactions.

The researcher has contributed extensively to the study of immune cells in cancer and cancer immunotherapy. Their key research topics include:

Immune cells in cancer
Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
CAR-T cell therapy research
Prostate Cancer Treatment and Research
Immune Cell Function and Interaction
T-cell and B-cell Immunology

Mario P. Colombo has published in several frequent venues, highlighting their active role in oncology and immunology research:

Cancer Research
Journal of Experimental & Clinical Cancer Research
bioRxiv (Cold Spring Harbor Laboratory)
Zenodo (CERN European Organization for Nuclear Research)
Cancer Immunology Immunotherapy

Some notable recent papers include:

"Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs", 2020, Cancer Research
"Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors", 2022, Cancer Research
"Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects", 2022, Cell Reports
"Infiltrating Mast Cell-Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype", 2020, Cancer Research
"Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells", 2022, Clinical Cancer Research

Their collaborative research involves frequent coauthors such as Sabina Sangaletti, Claudio Tripodo, Claudia Chiodoni, Elena Jachetti, and Valeria Cancila, illustrating sustained partnerships to advance cancer and immunology studies.

Mario P. Colombo's academic focus clearly prioritizes understanding immune interactions in cancer contexts, immune-mediated therapeutic strategies, and molecular mechanisms underlying tumor biology. This is demonstrated by a substantial body of work in immunology and oncology subfields, including molecular biology and pulmonary medicine.

Best Publications

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Vincenzo Bronte;Sven Brandau;Shu Hsia Chen;Mario P. Colombo

2813
Citations
The terminology issue for myeloid-derived suppressor cells.

Dmitry I. Gabrilovich;Vincenzo Bronte;Shu Hsia Chen;Mario P. Colombo

1014
Citations
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

Giovanna Gallina;Luigi Dolcetti;Paolo Serafini;Carmela De Santo

998
Citations
Interleukin-12 in anti-tumor immunity and immunotherapy

Mario P Colombo;Giorgio Trinchieri

925
Citations
Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.

Paola Paglia;Claudia Chiodoni;Monica Rodolfo;Mario P. Colombo

787
Citations
Redirecting In vivo Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection

Cristiana Guiducci;Alain P. Vicari;Sabina Sangaletti;Giorgio Trinchieri

701
Citations
Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.

Silvia G. Priori;Silvia G. Priori;Maurizio Gasparini;Carlo Napolitano;Paolo Della Bella

678
Citations
IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice

Vincenzo Bronte;Paolo Serafini;Carmela De Santo;Ilaria Marigo

654
Citations
Classification of current anticancer immunotherapies

Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

584
Citations
p50 Nuclear Factor-κB Overexpression in Tumor-Associated Macrophages Inhibits M1 Inflammatory Responses and Antitumor Resistance

Alessandra Saccani;Tiziana Schioppa;Chiara Porta;Subhra K. Biswas

583
Citations
The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

Emma Di Carlo;Guido Forni;PierLuigi Lollini;Mario P. Colombo

565
Citations
Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy

Mario P. Colombo;Silvia Piconese

523
Citations
Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.

Barbara Valzasina;Cristiana Guiducci;Cristiana Guiducci;Heidrun Dislich;Heidrun Dislich;Nigel Killeen;Nigel Killeen

511
Citations
CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.

Giorgia Gri;Silvia Piconese;Barbara Frossi;Vanessa Manfroi

481
Citations
The Promyelocytic Leukemia Zinc Finger–MicroRNA-221/-222 Pathway Controls Melanoma Progression through Multiple Oncogenic Mechanisms

Federica Felicetti;M. Cristina Errico;Lisabianca Bottero;Patrizia Segnalini

468
Citations
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells.

Antonio Curti;Simona Pandolfi;Barbara Valzasina;Michela Aluigi

467
Citations
Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake.

Stephen Todryk;Alan A. Melcher;Alan A. Melcher;Nicola Hardwick;Emmanouela Linardakis

466
Citations
Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity.

Sabina Sangaletti;Claudio Tripodo;Claudia Chiodoni;Carla Guarnotta

466
Citations
Bacterial communities and enzyme activities of PAHs polluted soils

V. Andreoni;L. Cavalca;M.A. Rao;G. Nocerino

453
Citations
Amino-Biphosphonate–Mediated MMP-9 Inhibition Breaks the Tumor-Bone Marrow Axis Responsible for Myeloid-Derived Suppressor Cell Expansion and Macrophage Infiltration in Tumor Stroma

Cecilia Melani;Sabina Sangaletti;Francesca M. Barazzetta;Zena Werb

453
Citations
Reversal of Tumor-induced Dendritic Cell Paralysis by CpG Immunostimulatory Oligonucleotide and Anti–Interleukin 10 Receptor Antibody

Alain P. Vicari;Claudia Chiodoni;Céline Vaure;Smina Aït-Yahia

450
Citations

Frequent Co-Authors

Claudio Tripodo FIRC Institute of Molecular Oncology

Giorgio Parmiani University of Siena

Guido Forni University of Turin

Piero Musiani University of Chieti-Pescara

Licia Rivoltini Fondazione IRCCS Istituto Nazionale dei Tumori

Emma Di Carlo University of Chieti-Pescara

Federica Cavallo University of Turin

Katia Scotlandi Wayne State University

Michele Maio University of Siena

Patrizia Nanni University of Bologna

External Links

Personal website of Mario P. Colombo

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career paths. Many students transition into nursing roles where understanding the immune system is crucial. Programs like online ABSN programs for non nurses offer accelerated routes for individuals without a nursing background, making the shift smoother and faster.

Accelerated study options are highly appealing, with 12-month accelerated nursing programs enabling students to earn their Bachelor of Science in Nursing quickly. These programs are ideal for career changers eager to enter clinical settings where immunological knowledge is valuable.

For those seeking quicker certification, the fastest and easiest LPN programs allow entry into nursing support roles. These positions often work closely with immunology specialists, providing a practical foundation in patient care related to immune system conditions.

Advanced practice nurses have options through nurse practitioner programs with easy admission. These degrees prepare professionals to work at the forefront of immunology-focused care, including diagnosing and managing immune-related diseases.